Jeffrey Glenn
Corporate Officer/Principal at Stanford University School of Medicine
Jeffrey Glenn active positions
Companies | Position | Start | End |
---|---|---|---|
Stanford University School of Medicine | Corporate Officer/Principal | 1999-12-31 | - |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - | - |
Career history of Jeffrey Glenn
Former positions of Jeffrey Glenn
Companies | Position | Start | End |
---|---|---|---|
EIGER BIOPHARMACEUTICALS, INC. | Director/Board Member | 2008-11-05 | 2024-03-31 |
Founder | 2008-11-05 | 2024-03-31 | |
Independent Dir/Board Member | 2008-11-05 | 2024-03-31 | |
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Director/Board Member | 2010-02-28 | 2016-02-29 |
Founder | 2010-02-28 | 2016-02-29 |
Training of Jeffrey Glenn
University of California, Berkeley | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Statistics
International
United States | 7 |
Operational
Director/Board Member | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Private companies | 2 |
---|---|
Eiger BioPharmaceuticals, Inc. /Old/
Eiger BioPharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Eiger BioPharmaceuticals, Inc. provides pharmaceutical products. It operates as a biopharmaceutical company, which focuses on the discovery and development of new antiviral agents against novel targets in the treatment of hepatitis. The firm’s pipeline includes clinical stage assets and preclinical new chemical entities (NCEs) shown to possess antiviral activity against Hepatitis C, Hepatitis D, and a wide array of other viruses. It also conducts multiple clinical proofs of concept studies in multiple clinical sites in HCV and HDV patients. The company was founded by Jeffrey S. Glenn in 2008 and is headquartered in Palo Alto, CA. | Health Technology |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology American Society for Clinical Investigation engages as a medical honor society. It focuses on physician-scientists in research, clinical care, and medical education. The company was founded by Samuel J. Meltzer in 1908 and is headquartered in Ann Arbor, MI. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Glenn
- Experience